环氧合酶 (COX) 的正式名称是前列腺素内过氧化物合酶 (PTGS),它是一种负责形成重要生物介质前列腺素类物质的酶,包括前列腺素、前列环素和血栓素。通过药物抑制 COX 可以缓解炎症和疼痛症状。抑制环氧合酶活性的药物(如阿司匹林)已经面世约 100 年。已鉴定出两种环氧合酶同工酶,分别称为 COX-1 和 COX-2。在许多情况下,COX-1 酶是组成性产生的(即胃粘膜),而 COX-2 是可诱导的(即炎症部位)。非甾体抗炎药 (NSAID),如阿司匹林和布洛芬,通过抑制 COX 发挥作用。主要的 COX 抑制剂是非甾体抗炎药 (NSAID)。
Cyclooxygenase (COX), officially known as prostaglandin-endoperoxide synthase (PTGS), is an enzyme that is responsible for formation of important biological mediators called prostanoids, including prostaglandins, prostacyclin and thromboxane. Pharmacological inhibition of COX can provide relief from the symptoms of inflammation and pain. Drugs, like Aspirin, that inhibit cyclooxygenase activity have been available to the public for about 100 years. Two cyclooxygenase isoforms have been identified and are referred to as COX-1 and COX-2. Under many circumstances the COX-1 enzyme is produced constitutively (i.e., gastric mucosa) whereas COX-2 is inducible (i.e., sites of inflammation). Non-steroidal anti-inflammatory drugs (NSAID), such as aspirin and ibuprofen, exert their effects through inhibition of COX. The main COX inhibitors are the non-steroidal anti-inflammatory drugs (NSAIDs).
(±)8(9)-EET 是花生四烯酸 (Arachidonic Acid) (MS-A69140) 经细胞色素 P450 环氧酶途径代谢产生的主要代谢产物之一,是 COX-1 和 COX-2 的有效底物,在 HEK293 细胞中激活 PPARα,并以 PPARα 依赖性和非依赖性方式抑制 IL-1β 诱导的 NF-κB 活性,而其 (8S,9R)-异构体 ((8S,9R)-EET) 可引起血管收缩,从而降低肾血浆流量和肾小球滤过率。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号